págs. 366-374
Inge M.G. J. Bronckers, Amy S. Paller, Dennis P. West, Irene Lara Corrales, Megha M. Tollefson, Wynnis L. Tom, Marcia Hogeling, Leah Belazarian, Claus Zachariae, Emmanuel Mahé, Elaine Siegfried, Ulrike Blume-Peytavi, Zsuzsanna Szalai, Ruth Ann Vleugels, Kristen E. Holland, Ruth Murphy, Kelly M. Cordoro, Jo Lambert, Alex Alexopoulos, Ulrich Mrowietz, Wietske Kievit, Marieke M.B. Seyger
págs. 384-392
Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis: A Randomized Clinical Trial
Selma Atalay, Juul M. P. A. van den Reek, Alfons A. den Broeder, Lieke J.van Vugt, Marisol E. Otero, Marcellus D. Njoo, Johannes M. Mommers, Paul M. Ossenkoppele, Marjolein Koetsier, Maartje A. Berends, Peter C.M. van de Kerkhof, Hans M. Groenewoud, Wietske Kievit, Elke M. G. J. De Jong
págs. 393-400
Louisa Gordon, Astrid J. Rodriguez-Acevedo, Brian Køster, Gery P. Guy, Craig A. Sinclair, Emilie Van Deventer, Adèle C. Green
págs. 401-410
Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial
Emma Guttman-Yassky, Andrew Blauvelt, Lawrence F. Eichenfield, Amy S. Paller, April W. Armstrong, M Janice Drew, Ramanan Gopalan, Eric L. Simpson
págs. 411-420
Prevalence, Incidence, and Risk of Cancer in Patients With Psoriasis and Psoriatic Arthritis
Sofie Vaengebjerg, Lone Skov, Alexander Egeberg, Nikolai Dyrberg Loft
págs. 421-429
© 2001-2025 Fundación Dialnet · Todos los derechos reservados